Collectively, these findings establish CCT4 as a marker of immune evasion in LUAD, characterized by reduced immune infiltration, functional paralysis of the cancer-immunity cycle, and upregulation of immunosuppressive signaling axes. The gene discussed is CCT4; the disease is cancer.